UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000015903
Receipt No. R000018510
Official scientific title of the study Evaluation of the efficacy of teriparatide for distal radial fracture repair after plate fixation in osteoporotic patients:A prospective randomized control study.
Date of disclosure of the study information 2015/01/01
Last modified on 2019/02/18 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Evaluation of the efficacy of teriparatide for distal radial fracture repair after plate fixation in osteoporotic patients:A prospective randomized control study.
Title of the study (Brief title) Evaluation of the efficacy of teriparatide for fracture repair.
Region
Japan

Condition
Condition osteoporosis
Classification by specialty
Orthopedics
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study is to evaluate the effectiveness of teriparatide for acceleration of fracture repair in osteoporotic patient with distal radial fractures.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Primary outcome is the comparison of the percent chage of bone mineral density (BMD)of the fracture site as measured by dual-energy x-ray absorptiometry(DEXA)with or without teriparatide administration from baseline to 24 weeks after surgery.
Key secondary outcomes Secondary outcome is the comparison of the percent change in markers of bone formation and resorption with or without teriparatide administration from baseline to 24 weeks after surgery.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking NO
Concealment Numbered container method

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Teriparatide 20 microg is administrated subcutaneously once daily for 24 weeks.
Interventions/Control_2 Active vitamine D3 1.0 microg is orally administrated once daily for 24 weeks.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)Distal radial fracture with surgical treatment
2)Gender:any gender
3)Age:any ages but correspond with diagnostic criteria for primary osteoporosis
4)Cases who have ability to consent to the study
5)case expected to attend a hospital regularly as planned
Key exclusion criteria 1)Primary malignant bone tumors or bone metastasis
2)Metabolic bone disease except primary osteoporosis
3)Under medication for osteoporosis(bisphosphonates, teriparatide, or SERM )
4)Under medication of steroid
5)Hypercalcemia
6)Suspection of metal allergy
7)Dementia, Schizophrenia, Panic disorder and other diseases that may have affect the evaluation or obstruct obtaining consent
Target sample size 20

Research contact person
Name of lead principal investigator Hirohiko Ota
Organization Yokohama City University Medical Center
Division name Orthopaedics
Address 4-57 Urafune-cho, Minami-ku, Yokohama City, 232-0024, Japan
TEL 045-261-5656
Email ota_1080@yokohama-cu.ac.jp

Public contact
Name of contact person Hirohiko Ota
Organization Yokohama City University Medical Center
Division name Orthopaedics
Address 4-57 Urafune-cho, Minami-ku, Yokohama City, 232-0024, Japan
TEL 045-261-5656
Homepage URL
Email ota_1080@yokohama-cu.ac.jp

Sponsor
Institute Yokohama City University Medical Center
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization JAPAN

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 横浜市立大学附属市民総合医療センター(神奈川県)

Other administrative information
Date of disclosure of the study information
2015 Year 01 Month 01 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2014 Year 06 Month 25 Day
Anticipated trial start date
2015 Year 01 Month 01 Day
Last follow-up date
2016 Year 09 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2014 Year 12 Month 10 Day
Last modified on
2019 Year 02 Month 18 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018510